AMDL Inc. (ADL) announced that it's wholly owned subsidiary, Jade Pharmaceutical Inc., has signed a letter of intent with China-based Sichuan ZhiTong Pharmaceutical Ltd.
Under the terms of the letter of intent, Jade Pharmaceutical and Sichuan ZhiTong Pharmaceutical would consolidate sales forces and enter into a distribution agreement where the Sichuan ZhiTong would distribute additional AMDL pharmaceutical products including GoodNak, Levofloxicin and Ondansetron.
The company noted that Sichuan ZhiTong sells and distributes traditional Chinese medicines, health foods, medical equipment, and generic pharmaceutical products.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.